Starting in June, Colorado’s Medicaid agency will cover a breakthrough hepatitis C drug on a case-by-case basis, while it decides who will qualify for the potentially life-saving drug, and who will not.
It's MORNING EDITION, from NPR News. Good morning. I'm David Greene.
STEVE INSKEEP, HOST:
And I'm Steve Inskeep.
Even before the events of the last few days, Congress had a busy agenda. Lawmakers are negotiating over taxes and spending that could affect the economy in the year ahead, not to mention almost every part of the federal government and the take-home pay for millions of Americans.